Camad, Baina C.

HRN: 28-94-77  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/29/2026
05/06/2026
IV
25mg
Q 8 Hours
Bacterial Skin Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: